Status:
COMPLETED
Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy
Lead Sponsor:
Kyungpook National University Chilgok Hospital
Conditions:
Stomach Neoplasm
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a prospective, randomized controlled trial to investigate the impact of a long biliopancreatic limb of Roux-en-Y reconstruction on diabetes control in patients with concurrent type 2 diabetes ...
Detailed Description
The present study aimed to compare the changes in glucose metabolism and incretin hormone responses following long-limb bypass Roux-en-Y reconstruction with different biliopancreatic limb lengths afte...
Eligibility Criteria
Inclusion
- Patients diagnosed with type 2 diabetes as well as pathologically proven gastric cancer of clinical stage I according to the AJCC 8th edition
- Those who are expected to undergo laparoscopic distal gastrectomy
Exclusion
- baseline fasting C-peptide level \< 1.0 ng/dL (who had the possibility of type 1 diabetes)
- previous radiotherapy or surgery at upper abdomen other than laparoscopic cholecystectomy
- other malignancies in recent 5 years
- vulnerable patients (pregnant women, those with cognitive impairment, etc)
- ECOG-PS ≥ 2
- participating in other clinical trials within 6 months
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04889859
Start Date
May 1 2019
End Date
February 28 2023
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyungpook National University Chilgok Hospital
Daegu, South Korea, 41404